Back to all studies
RecruitingNCT04046497

Artificial Intelligence to Measure Adherence to Oral Medication

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

SchizophreniaBehavioralFrom 15 Years to 40 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT04046497. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether a study medication may be useful for people experiencing schizophrenia.

What would participation involve?

Participants may receive a study medication, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in United States.

Who is it mainly for?

This study appears to be mainly for people with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

The official record suggests a mix of remote and in-person participation through a hospital, with sites including Citrus Health in Hialeah, InterAct in Grand Rapids, and InterAct of Michigan in Kalamazoo. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually meeting the main study requirements. This is a later-stage study, which usually means the approach is being followed in broader real-world use.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: November 20, 2020
Recruitment status
Recruiting
Estimated enrollment
Not clearly listed
Sponsor
Northwell Health
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Behavioral / psychological / psychosocial
Study phase
Not clearly listed
Locations
United States
Age range
From 15 Years to 40 Years
Official registry ID
NCT04046497
Official title
Artificial Intelligence to Measure Adherence to Oral Medication
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT04046497. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help test a support approach in real life.

It requires regular visits and structured follow-up.

Mixes in-person and remote participation.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring digital app or tool for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study. Phase is mainly useful to check for medication studies and some device studies.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 15 Years to 40 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Could this study affect my mood, habits, motivation, or stress?

Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Northwell Health, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study is currently recruiting. This does not mean you are eligible: the study team must confirm the criteria, available locations, and next steps.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me